Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
---|
04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
04/27/2005 | CN1198793C Ethers of methyl venlafaxine |
04/26/2005 | CA2165830C Salmeterol xinafoate with controlled particle size |
04/21/2005 | WO2005036275A1 Electrophotographic photoreceptor and image forming apparatus including the same |
04/21/2005 | WO2005014525A3 Bi-aryl compound having immunosuppressive activity |
04/21/2005 | US20050085524 Fungicides, bactericides, insecticides |
04/21/2005 | US20050084943 New conditions for reactions mediated by yeast |
04/21/2005 | US20050082231 reducing the aggregation and deposition of asphalts or bitumen from fluids such as crude oil, by adding to the fluids antideposit agents such as hexadecyl naphthoxide; reducing particle and/or soot emission during combustion of diesel fuel; pollution control |
04/20/2005 | EP0916637B1 Process for preparating optically active compounds |
04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
04/20/2005 | CN1608049A Method for preparing benzyl cyanide compound |
04/14/2005 | US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
04/13/2005 | EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent |
04/13/2005 | EP1031555B1 Difluoromethoxybenzene derivatives and their use as intermediates |
04/13/2005 | CN1196464C Novel coloring agent for use in oxidative hair dyeing |
04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
04/12/2005 | US6878821 Modifying chemoselectivity during oxidation of nitrogen compounds |
04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
04/07/2005 | US20050075505 Reacting 3-(3,5-dimethylphenoxy)-2-hydroxypropylamine with such as ethyl chloroformate under alkaline conditions; high yield; reduced energy |
04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
04/06/2005 | EP1519940A1 Substituted aryl boronic acids, their preparation and their precursors |
04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
04/06/2005 | CN1604918A Monoamide based catalyst compositions for the polymerization of olefins |
04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
04/06/2005 | CN1603303A Preparation of N-methylated amines from selective vapor phase amination of amino ether alcohols |
04/06/2005 | CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same |
04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
04/05/2005 | US6875850 Reagent for labelling nucleic acids |
04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
03/31/2005 | WO2005028457A1 Preparation of quetiapine |
03/31/2005 | DE10341533A1 Verfahren zur Herstellung von halogenhaltigen 4-Aminophenolen Process for the preparation of halogenated 4-aminophenols |
03/30/2005 | EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
03/30/2005 | EP1517879A1 Aminoalkylphenols, methods of using and making the same |
03/30/2005 | EP1296933B1 Self-reducible copper(ii) source reagents for chemical vapor deposition of copper metal |
03/30/2005 | CN1602291A Novel bensophenone derivatives or salts thereof |
03/30/2005 | CN1602184A Compounds for a controlled release of active molecules |
03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
03/29/2005 | US6872741 Sodium channel modulators |
03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
03/24/2005 | WO2005000775A3 Cyclohexyl derivatives as selective estrogen receptor modulators |
03/24/2005 | WO2004071426A3 Compounds for the treatment of viral infection |
03/24/2005 | WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
03/24/2005 | WO2004041896A8 Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials |
03/23/2005 | EP1515940A2 Aminoalkoxy-functional chalcones |
03/23/2005 | CN1599715A Venlafaxine hydrochloride monohydrate and methods for the preparation thereof |
03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
03/22/2005 | US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation |
03/22/2005 | US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
03/17/2005 | WO2005023744A2 Calixarenes as inhibitors of protein kinase b |
03/17/2005 | WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs |
03/17/2005 | CA2538372A1 Calixarenes as inhibitors of protein kinase b |
03/16/2005 | EP1514865A1 Process for the preparation of halogen containing 4-amino phenols |
03/16/2005 | EP1513825A2 Anti tubercular drug: compositions and methods |
03/16/2005 | EP1513795A2 Propionic acid derivatives and their use as hppars activators |
03/16/2005 | CN1596248A Phenoxy amine compounds and compositions for delivering active agents |
03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
03/10/2005 | WO2005000795A3 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
03/10/2005 | US20050054882 Diaryl ether condensation reactions |
03/10/2005 | US20050054872 Hydrogenation of cyanoethylated alcohols, i.e. by reacting an alcohol with meth)acrylonitrile, utilizing an ether or amide solvent that solubilizes byproduct (meth)acrylonitrile and poly(meth)acrylonitrile present in the feedstock or produced during the hydrogenation; kinetics; durability of catalyst |
03/10/2005 | US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
03/10/2005 | US20050052133 Bis(aminostyryl)naphthalene compound, synthesis intermediate thereof, and process for production thereof |
03/09/2005 | EP1512675A1 Aminopropylation of alcohols in the presence of amide or ether solvents |
03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
03/09/2005 | CN1590366A Improved method of preparing bisolol and its salt |
03/09/2005 | CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same |
03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
03/08/2005 | US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
03/03/2005 | WO2005019164A2 Preparation of phenethanolamine derivatives |
03/03/2005 | WO2004101581A3 Nitrogen-containing monodentate phosphines and their use in catalysis |
03/03/2005 | US20050049304 comprises the steps of preparing a mixture of venlafaxine with acetone then exposing the mixture to gaseous hydrochloric acid |
03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
03/02/2005 | EP1509222A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
03/02/2005 | EP1232279B1 Method for producing optically active amines |
03/02/2005 | CN1587254A Separating device and method for dimethyl amino ethyl ether |
03/02/2005 | CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method |
03/02/2005 | CN1191230C Method for preparing neurainidase inhibitor RO-64-0796 |
03/01/2005 | US6861560 Bis-o-aminophenols and processes for producing bis-o-aminophenols |
03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
02/24/2005 | WO2005016865A1 Gamma hydroxy carbamate compounds and methods of making and using the same |
02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
02/24/2005 | US20050043534 Modulators of ceramidase and methods of used based thereon |
02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
02/24/2005 | US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia |
02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
02/23/2005 | EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists |
02/23/2005 | EP1507521A1 Metabolite of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentane-3-ol and the use thereof in the treatment of urinary incontinence |